De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-13
DOI
10.1038/s41598-019-48034-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights
- (2017) Sheeja Aravindan et al. Scientific Reports
- Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells
- (2016) Sheeja Aravindan et al. Oncotarget
- Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
- (2016) Satish Kumar Ramraj et al. Oncotarget
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
- (2015) Faizan H. Khan et al. BMC CANCER
- Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells
- (2015) Faizan H Khan et al. BMC GENOMICS
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes
- (2015) Faizan H. Khan et al. Oncotarget
- Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling
- (2015) Vijayabaskar Pandian et al. Stem Cell Research & Therapy
- Recent insights into the biology of neuroblastoma
- (2014) Gudrun Schleiermacher et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- The Novel Long Noncoding RNA linc00467 Promotes Cell Survival but Is Down-Regulated by N-Myc
- (2014) Bernard Atmadibrata et al. PLoS One
- Insights into the role of RD3 in guanylate cyclase trafficking, photoreceptor degeneration, and Leber congenital amaurosis
- (2014) Laurie L. Molday et al. Frontiers in Molecular Neuroscience
- Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
- (2013) E. Barbieri et al. CANCER RESEARCH
- RD3 gene delivery restores guanylate cyclase localization and rescues photoreceptors in the Rd3 mouse model of Leber congenital amaurosis 12
- (2013) L. L. Molday et al. HUMAN MOLECULAR GENETICS
- Current and Future Strategies for Relapsed Neuroblastoma
- (2013) Daniel A. Morgenstern et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Union Makes Strength: A Worldwide Collaborative Genetic and Clinical Study to Provide a Comprehensive Survey of RD3 Mutations and Delineate the Associated Phenotype
- (2013) Isabelle Perrault et al. PLoS One
- New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome
- (2012) K. A. Cole et al. CLINICAL CANCER RESEARCH
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Cancer sequencing unravels clonal evolution
- (2012) Carlos Caldas NATURE BIOTECHNOLOGY
- Retinal Degeneration 3 (RD3) Protein Inhibits Catalytic Activity of Retinal Membrane Guanylyl Cyclase (RetGC) and Its Stimulation by Activating Proteins
- (2011) Igor V. Peshenko et al. BIOCHEMISTRY
- Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2011) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials
- (2010) Thorsten Simon et al. PEDIATRIC BLOOD & CANCER
- RD3, the protein associated with Leber congenital amaurosis type 12, is required for guanylate cyclase trafficking in photoreceptor cells
- (2010) S. Azadi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
- (2009) Alberto Garaventa et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease control intervals in high-risk neuroblastoma
- (2008) Victor M. Santana et al. CANCER
- Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
- (2008) J. J. Molenaar et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started